RxDoctor Payments Data

David Justice, MD

Psychiatry · Sumter, SCNPI 1649290362

Payments from drug & device makers

$2,852in general payments, 2019–2025

Across 159 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$466
  • Neurocrine Biosciences, Inc.$379
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$343
  • Otsuka America Pharmaceutical, Inc.$295
  • AbbVie$236
  • Sunovion Pharmaceuticals Inc.$227
  • plus $906 from 13 others

What the payments were for

  • Food & beverage$2,79298%
  • Education$602%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,852 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$23,878
Medicare patients
97
Services billed
400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine30$343,039
Invega SustennaPaliperidone Palmitate70$198,808
AristadaAripiprazole Lauroxil18$62,579
Abilify MaintenaAripiprazole12$34,807
RexultiBrexpiprazole15$25,623
Lurasidone Hcl29$17,914
TrintellixVortioxetine Hydrobromide14$8,643
VyvanseLisdexamfetamine Dimesylate14$5,477
Divalproex Sodium ErDivalproex Sodium30$3,310
Oxcarbazepine40$2,414
Aripiprazole91$1,942
Ziprasidone Hcl41$1,818
Fluphenazine Hcl11$1,652
Quetiapine Fumarate117$1,576
Hydroxyzine Hcl51$1,439

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$159$343,03930 claims
Johnson & JohnsonInvega Sustenna$466$198,80870 claims
Alkermes, Inc.Aristada$178$62,57918 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$295$60,43027 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$143$14,12028 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Sumter

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →